Interference screws have proven to be an effective means for securing tissue in a bone tunnel. However, the interference screw itself generally takes up a substantial amount of space within the bone tunnel, which can limit the surface area contact established between the tissue and the side wall of the bone tunnel. This in turn limits the region of bone-to-tissue in-growth, and hence can affect the strength of the repair. By way of example but not limitation, it has been estimated that the typical interference screw obstructs about 50% of the potential bone-to-tissue integration region.
In one aspect, the present disclosure relates to an open-architecture interference screw for creating an interference fit between a bone tunnel and tissue. The interference screw includes a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end. The interference screw further includes a supporting spline extending along a cannulation through the threaded body between the proximal end and distal end. The supporting spline is engagable with a delivery device. The interference screw further includes at least one opening defined by an outer surface between the thread. The at least one opening is further defined by a ratio of open surface area to closed surface area. The ratio is selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel. The interference screw further includes a tapered tip extending from the distal end of the threaded body. The tapered tip has a thread extending at least partway around the tapered tip.
In yet another aspect, the present disclosure relates to a delivery device and interference screw combination for creating an interference fit between a bone tunnel and tissue. The delivery device of the combination includes a handle and a shaft connected to the handle. The shaft includes a distal portion having a driving member. The interference screw includes a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end. The interference screw further includes a supporting spline extending along a cannulation through the threaded body between the proximal end and distal end. The supporting spline is engagable with a delivery device. The interference screw further includes at least one opening defined by an outer surface between the thread. The at least one opening is further defined by a ratio of open surface area to closed surface area. The ratio is selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel. The interference screw further includes a tapered tip extending from the distal end of the threaded body. The tapered tip has a thread extending at least partway around the tapered tip. The interference screw is located on the distal portion of the delivery device such that the driving member engages the supporting spline of the interference screw.
In some examples, the interference screw may further include one or more of the following, alone or in any combination. The thread of the tapered tip may extend at least one full turn around the tapered tip. The thread of the tapered tip may also be a continuation of the thread of the threaded body. In other examples, the thread of the tapered tip is a partial thread extending less than one full turn around the tapered tip. Some of these examples include a first partial thread and a second partial thread, each extending a half turn around the tapered tip.
In some examples, the threaded body and tapered tip each have a different thread pitch. The thread pitch of the tapered tip may be between 1.5 and 3 times greater than the thread pitch of the threaded body.
In other examples, the threaded body has a constant diameter. The threaded body may have a wall thickness of 0.5-3.25 mm or a wall thickness that is a function of the diameter and length of the screw. The supporting spline may have a width of 1-2.5 mm. The thread of the threaded body may have a base width of 0.76-2.54 mm.
In some examples, the ratio of open surface area to closed surface area is a function of the diameter and length of the screw. In one example, in which the screw has a diameter of 11-12 mm and a length of 30-35 mm, the ratio is about one unit of open surface area to about three units of closed surface. In another example, in which the screw has a diameter of 7-10 mm and a length of 20-35 mm, the ratio is about one unit of open surface area to about four units of closed surface area. In yet another example, in which the screw has a diameter of 5-6 mm and a length of 20-25 mm, the ratio is about one unit of open surface area to about five units of closed surface area.
The at least one opening may be defined by a surface between adjacent proximal threads. Alternatively, the at least one opening may include at least one continuous opening between adjacent proximal threads and at least one discontinuous opening between adjacent distal threads. In this example, the at least one discontinuous opening has alternating segments of open surface area and closed surface area. In yet another example, the at least one opening is defined by a surface between alternating pairs of adjacent threads.
Other examples of the interface screw include a screw head comprising a surface extending from the threaded body into a hemispherical-like end portion.
Some examples of the interface screw are made from made from a combination of poly(lactic-co-glycolic) acid, β-Tricalcium phosphate, and calcium sulfate.
Further areas of applicability of the present disclosure will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating the convenient example of the disclosure, are intended for purposes of illustration only and are not intended to limit the scope of the disclosure.
The accompanying drawings, which are incorporated in and form a part of the specification, illustrate examples of the present disclosure and together with the written description serve to explain the principles, characteristics, and features of the disclosure. In the drawings:
The following description of the example is in no way intended to limit the disclosure, its application, or uses.
Having a ratio of open surface area to closed surface area is particularly advantageous, inasmuch as the ratio provides the structural strength (e.g., torsional, flexural, and/or compressive strengths) needed to set the interference screw 100 into position, and hold the tissue in position while bone-to-tissue in-growth occurs, while still providing extraordinary access through the threaded body 105 of the interference screw 100. Thus, cell and nutrient-bearing fluids can move substantially unimpeded through the threaded body 105 of interference screw 100, and tissue in-growth can occur across the threaded body 105 of interference screw 100.
A convenient example of the interference screw 100 has a ratio of open surface area to closed surface area that is a function of the diameter and length of the interference screw 100. For example, the ratio of open surface area to closed surface area increases as the length and/or diameter of the interference screw 100 increases. Described below in greater detail, a large-sized example of the interference screw 100, having a diameter of 11 mm-12 mm and a length of 30 mm-35 mm, has a ratio of about one unit of open surface area to about three units of closed surface area. A medium-sized example of the interference screw 100, having a diameter of 7 mm-10 mm and length of 20-35 mm, has a ratio of about one unit of open surface area to about four units of closed surface area. A small-sized example of the interference screw 100, having a diameter of 5-6 mm and a length of 20 mm-25 mm, has a ratio of about one unit of open surface area to about five units of closed surface area.
As best seen in
A convenient example of the interference screw 100 has a uniform taper 135. The threaded body 105 tapers from the proximal end 106 to the distal end 107. The taper 135 is advantageous to creating an interference fit between tissue and bone tunnel. When the interference screw 100 is inserted into the bone tunnel, the surface of the taper 135 fully contacts the tissue and drives it laterally into engagement with the opposing side wall of the bone tunnel. Greater contact between the interference screw 100 and tissue increases the pullout strength of the interference screw 100 and/or tissue.
The interference screw 100 further includes a cannulation 140 within the threaded body 105. The cannulation 140 extends longitudinally between the proximal end 106 and distal end 107 of the threaded body 105. In other words, the interference screw 100 may include an open helical coil defining an internal volume. The internal volume communicates with a region exterior to the open helical coil through the at least one opening 115 between the threads of the threaded body 105. There is a supporting spline 145 (three shown) extending longitudinally along the cannulation 140. The cannulation 140 and supporting spline 145 cooperatively engage a driver. The use of two or more supporting spline 145, rather than one supporting spline 145, may be advantageous because it may distribute the load imposed during rotation over a larger surface area.
The distal end 156 of the shaft 155 is placed within the cannulation 140 of the interference screw 100 until the depth stop engages the distal stop 165 of the shaft 155. At this stopping point, the entire length of the interference screw 100 is fully supported by the driver 150. When the interference screw 100 is fully supported, the interference screw 100 is engaged by the driver 150, distributing the load across the entire length of the interference screw 100.
During insertion of the shaft 155 into the interference screw 100, the supporting splines 145 engage the grooves 160 and become housed within the grooves 160. A convenient example of the driver 150 includes a groove 160 for receiving substantially an entire length of the supporting spline 145. The interference screw 100 being mounted on the driver 150 such that the supporting spline 145 is substantially captured by the groove 160 of the driver 150. Rotating the driver 150 causes the interference screw 100 to rotate.
In example shown in
A convenient example of the driver 100 includes a tapered seat-forming thread (e.g., a tapered cutting thread, a tapered opening or dilating thread, etc.) formed in shaft distal to the grooves. Tapered seat-forming thread serves to precede interference screw into the space between the tissue and the wall of the bone tunnel, and then to form a lead-in or opening in the tissue and the wall of the bone tunnel for receiving the threads of threaded body, in much the same manner as a tap that creates a thread form.
During tissue (e.g., ligament) reconstruction surgery, for example, the end of the tissue (e.g., graft ligament) is placed in the bone tunnel and then the interference screw 100 is advanced into the bone tunnel via the use of driver 150 so that the interference screw 100 extends parallel to the bone tunnel and simultaneously engages both the tissue and the side wall of the bone tunnel. The interference screw 100 may be used in either the femoral or tibial tunnels, for example.
In one example of the interference screw 200, the threaded body 205 has a constant diameter. In another example of the interference screw 200, the threaded body 205 includes a taper different than the taper 215 of the tip 210. The threaded body 205 tapering from the proximal end to distal end (e.g., a 2 degree taper). The taper of the threaded body 205 is advantageous to creating an interference fit between tissue and bone tunnel. When the interference screw 200 is inserted into the bone tunnel, the surface of the taper fully contacts the tissue and drives it laterally into engagement with the opposing side wall of the bone tunnel. Greater contact between the interference screw 200 and tissue increases the pullout strength of the interference screw 200 and/or tissue. Because of the taper 215 of the tip 210, this example of the interference screw 200 is also easier to insert into a bone tunnel.
A majority of the threaded body 205 includes screw threads 220 in the form of a helical coil, i.e. a connected series of continuous regularly spaced turns extending in a helical or spiral form substantially from the proximal end 206 to the distal end 207. The interference screw 200 further includes at least one opening 225 being defined by a surface between the threads 220 of the threaded body 205. The opening 225 is further defined by a ratio of open surface area to closed surface area. This ratio is advantageous to promoting desirable bone-to-tissue in-growth through the opening 225. This ratio is also advantageous to providing structural strength (e.g., torsional and/or flexural), such that the interference screw 200 resists breaking when inserted into an undersized bone tunnel to create an interface fit between a bone tunnel and tissue. It may convenient to refer to the ratio as a measure of degree of openness of an open architecture interference screw.
A convenient example of the interference screw 200 has a ratio of open surface area to closed surface area that is a function of the diameter and length of the interference screw 200. For example, the ratio of open surface area to closed surface area increases as the length and/or diameter of the interference screw 200 increases. Described below in greater detail, a large-sized example of the interference screw 200, having a diameter of 11 mm-12 mm and a length of 30 mm-35 mm, has a ratio of about one unit of open surface area to about three units of closed surface area. A medium-sized example of the interference screw 200, having a diameter of 7 mm-10 mm and length of 20-35 mm, has a ratio of about one unit of open surface area to about four units of closed surface area. A small-sized example of the interference screw 200, having a diameter of 5-6 mm and a length of 20 mm-25 mm, has a ratio of about one unit of open surface area to about five units of closed surface area.
As best seen in
The interference screw further includes a cannulation 245 within the threaded body 205. The cannulation 245 extends longitudinally between the proximal end 206 and distal end 207 of the threaded body 205. In other words, the interference screw 200 may include an open helical coil defining an internal volume. The internal volume communicates with a region exterior to the open helical coil through the at least one opening 225 between the threads 220 of the threaded body 205. There is a supporting spline 250 (four shown) extending longitudinally along the cannulation 245. The cannulation 245 and supporting spline 250 cooperatively engage a driver.
A convenient example of the interference screw 200 includes, at the proximal end 206, a screw head 290. The screw head 290 has a surface 290a that extends smoothly and continuously from the threaded body 205 into a hemispherical-like end portion 290b, as shown. In use, the screw head 290 rests against graft material and damage to graft fibers is possible. Beneficially, this arrangement of the surface 290a and hemispherical-like end portion 290b reduces the chance of such damage.
The interference screw 200 further includes a distal portion of discontinuous openings 260. The discontinuous openings are defined by a surface between distal threads 240a,b. Along a path of the surface, the surface alternates openings 225 and closed surface areas 235. This alternating pattern of openings 225 and closed surface areas 235 improves the torsional and flexural strength of the distal portion of the interference screw 200 that advantageous to insert in the interference screw 200 into a bone tunnel.
In the example of the interference screw 200 shown, the openings 225 and closed surface areas 235 of the distal portion of discontinuous openings are arranged 90° to each other. For example, there is opening 225 and when the interference screw 200 is rotated 90°, there is a closed surface area 235. It may be convenient to call this arrangement of the openings 225 and closed surface areas 235 asymmetrical. Other arrangements are possible, for example the openings 225 and closed surface areas 235 are arranged at an angle less than 90° or greater than 90°. The interference screw 200 with asymmetrical arrangement of openings 225 and closed surface areas 235 has a tip strength greater than an interference screw with openings only. High tip strength is advantageous to inserting the interference screw 200 into a undersized bone tunnel.
The example of the interference screw 200 may be described as having a threaded body 205 with a number of sides (e.g., four). The first side of the threaded body 205 includes a first series of rectangular-shaped (or the regular shape) openings 265 extending from the proximal end 206 to the distal end 207 of the interference screw 200. (Best seen in
The result of the foregoing arrangement is a region near the distal end 207 of the interference screw 200 in which the openings 225 are between closed surface areas 235. The strength of the surrounding closed surface areas 235 compensate for the weakness caused by the openings 225 in the interference screw 200. This arrangement improves tip strength that is advantageous to inserting the interference screw 200 into a bone tunnel.
The distal end 306 of the shaft 305 is placed within the cannulation 245 of the interference screw 200. When inserting the interference screw 200 into the bone tunnel, the entire length of the interference screw 200 is fully supported by the driver 300. This distributes the load across the entire length of the interference screw 200, reducing the risk of breakage during insertion.
In example shown in
An example of the tapered tip 410 has a first partial thread 430 and second partial thread 435 extending partway or less than 360° around the tapered tip 410. The first and second threads 430, 435 each start and stop at different locations on the surface 425 of the tapered tip 410. In a convenient example of the tapered tip 410, the first partial thread 430 starts in the distal region 420 at point 440a and extends about 180° around the tapered tip 410 (best seen in
In one example of the tapered tip 410, the partial threads 430, 435 taper towards the proximal region 415 with the same taper as the tapered tip 410. The minimum diameter of a given partial thread is at the distal terminus of the partial thread. The diameter of the partial thread increases to a maximum towards the proximal region 415 of the tapered tip 410. In a convenient example, the partial threads 430, 435 each have tapered ends, of which tapered ends 430a and 435a are shown in
Tracing an example of the partial thread with tapered ends, starting from the distal terminus of the partial thread, the diameter of the partial thread increases until a maximum is reached near the proximal region 415. Continuing to trace the partial thread past the maximum diameter, the diameter of the partial thread decreases until the proximal terminus of the partial thread is reached. In foregoing example, the partial thread extends about 180° around the tapered tip 410 but reaches a maximum diameter (and maximum root diameter) in less than 180°.
A convenient example of the tapered tip 410 has partial threads with a constant height and width. Another example of the tapered tip 410 has partial threads that are larger in the distal region 420 and decrease in size towards the proximal region 415. This arrangement provides an aggressive initial bite or purchase of surrounding tissue. Another example of the tapered tip 410 has partial threads that are smaller in the distal region 420 and increase in size towards the proximal region 415. This arrangement provides an initial bite less aggressive than the prior example.
In a convenient example of the tapered tip 410, the partial threads have a thread pitch greater than that of the threaded body 405. For example, the thread pitch of the partial threads on the tapered tip 410 is one-and-a-half to two times that of the threaded body 405. The larger thread pitch of the partial thread allows the tapered tip 410 to rapidly engage the surrounding tissue or bone tunnel.
While the foregoing examples of the tapered tip 410 are described as having two partial threads, it should be apparent that any number of partial threads are possible, such as three or four. For example,
In some examples of the interference screw 100, 200, 400 the threaded body 105, 205, 405 has a wall thickness of 0.5-3.25 mm. In other examples of the interference screw 100, 200, 400 the threaded body 105, 205, 405 has a wall thickness that is a function of the diameter and length of the screw.
In some examples of the interference screw 100, 200, 400 the supporting spline(s) 145, 250 has a width of 1-2.5 mm. Advantageously, a wide supporting spline distributes a torsional load better than a narrower supporting spline.
In some examples, the interference screw 100, 200, 400 may be completely or a portions thereof (e.g., the threaded body) made from a formulation of poly(lactic-co-glycolic) acid (PLGA), β-Tricalcium phosphate (β-TCP) and calcium sulfate, poly-L-lactic acid-hydroxyapatite (PLLA-HA), poly-D-lactide (PDLA), polyether ether ketone (PEEK) or variants thereof. Biocomposite examples of the interference screw 100, 200, 400 made from a combination of PLGA, β-TCP, and calcium sulfate are absorbable by the body, which is beneficial to natural healing. An example formulation of PLGA, β-TCP, and calcium sulfate is described in U.S. Pat. No. 8,545,866, the entirety of which is herein incorporated by reference. A copolymer of polyglycolic acid (PGA) and polytrimethylene carbonate (TMC) is another example of a bioabsorbable material. Other commonly used materials for implants are also contemplated by this disclosure. In any case, the interference screw 100, 200, 400 comprise a material that is capable of providing the strength needed to set the fixation device into position and to hold the tissue in position while bone-to-tissue in-growth occurs.
To examine the performance of the open-architecture interference screw, finite element analysis was used to simulate inserting the screw into an undersized bone tunnel with a delivery device. In the analysis, torque (torsional load) was applied to the inner portion of the screw that is in contact with the delivery device while the distal end of the screws was held in place. The torque at which the sample plastically deformed was recorded as the failure torque. The failure torque provides a measure of the torsional strength of a screw. The results of the analysis for a medium-size or 7 mm×25 mm (diameter by length) interference screw made from the formulation of PLGA, β-TCP, and calcium sulfate, described above, is provided below. (Similar results were found when the interference screw is made from PLLA-HA.)
A control with no openings (i.e., solid screw) had the highest failure torque (18.26 in*lb). From this baseline, samples of increasing degrees of openness were analyzed. In some samples, the degree of openness was attached with openings. In other samples, supporting splines or thread defining the openings were adjusted as well. It was observed that increasing the degree of openness decreased the failure torque.
Unexpectedly, increasing the degree of openness to one unit of open surface area to three units of closed surface area did not further decrease the torsional strength of the screw total but improved the torsional strength (increased from 13.86 to 16 in*lb). Increasing the degree of openness beyond this ratio, however, did not improve the performance but rather decreased performance (decreased from 16 to 13.33 in*lb). The results, therefore, demonstrate that for a medium-sized screw (e.g., 8 mm×25 mm), a ratio of about one unit of open surface area to about four units of closed surface area provides superior results. The results also demonstrated that, surprisingly, thickening the supporting splines provided better performance then thickening the threads of the screw.
Similar testing was performed with other sizes of screws. For a large-sized screw (e.g., 12 mm×25 mm), a ratio of about one unit of open surface area to about three units of closed surface area was determined to provide superior results. For a small-sized screw (e.g., 6 mm×20 mm), a ratio of about one unit of open surface area to about five units of closed surface area was determined to provide superior results. In some examples, increasing the wall thickness of the screw (e.g., when increasing the size of the screw), also increased the degree of openness.
For a large-sized screw (e.g., 12 mm×25 mm) made from PEEK, a ratio of about one unit of open surface area to about two units of closed surface area was determined to provide superior results. For a medium-sized screw (e.g., 8 mm×25 mm) made from PEEK, a ratio of about one unit of open surface area to about two units of closed surface area and a half was determined to provide superior results. For a small-sized screw (e.g., 6 mm×20 mm) made from PEEK, a ratio of about one unit of open surface area to about three and a half units of closed surface area was determined to provide superior results.
As various modifications could be made to the examples, as described above with reference to the corresponding illustrations, without departing from the scope of the disclosure, it is intended that all matter contained in the foregoing description and shown in the accompanying drawings shall be interpreted as illustrative rather than limiting. Thus, the breadth and scope of the present disclosure should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims appended hereto and their equivalents. As used herein, the meaning of approximately, substantially, and about include their ordinary and customary meanings as well as being a certain percentage of a stated value e.g., 0.1%, 1%, and 10%.
This application claims the benefit of U.S. Provisional Application No. 61/810,007, filed on Apr. 9, 2013, and entitled, “Open-architecture Interference Screw,” the entirety of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2288864 | Whitehead et al. | Jul 1942 | A |
3316795 | David | May 1967 | A |
3320783 | Kerr | May 1967 | A |
3499222 | Linkow et al. | Mar 1970 | A |
3716058 | Tanner | Feb 1973 | A |
3821975 | Haker | Jul 1974 | A |
3869942 | DeCaro | Mar 1975 | A |
3874258 | Semola et al. | Apr 1975 | A |
4027572 | Burge | Jun 1977 | A |
4177797 | Baylis et al. | Dec 1979 | A |
D288777 | Kwon | Mar 1987 | S |
4653489 | Tronzo | Mar 1987 | A |
4738255 | Goble et al. | Apr 1988 | A |
4741651 | Despres | May 1988 | A |
4834757 | Brantigan | May 1989 | A |
4854311 | Steffee | Aug 1989 | A |
RE33114 | Chiavon | Nov 1989 | E |
4913143 | Oloff et al. | Apr 1990 | A |
4961740 | Ray et al. | Oct 1990 | A |
4988351 | Paulos et al. | Jan 1991 | A |
5026373 | Ray et al. | Jun 1991 | A |
5055104 | Ray | Oct 1991 | A |
5094133 | Schreiber | Mar 1992 | A |
5116337 | Johnson | May 1992 | A |
5129904 | Illi | Jul 1992 | A |
5129906 | Ross et al. | Jul 1992 | A |
5139520 | Rosenberg | Aug 1992 | A |
5197967 | Wilson | Mar 1993 | A |
5236431 | Gogolewski et al. | Aug 1993 | A |
5242447 | Borzone | Sep 1993 | A |
5312214 | Morton | May 1994 | A |
5354299 | Coleman | Oct 1994 | A |
5364400 | Rego, Jr. et al. | Nov 1994 | A |
5370662 | Stone et al. | Dec 1994 | A |
5383878 | Roger et al. | Jan 1995 | A |
5407427 | Zhu et al. | Apr 1995 | A |
5411506 | Goble et al. | May 1995 | A |
5411523 | Goble | May 1995 | A |
5423823 | Schmieding | Jun 1995 | A |
5431660 | Burke | Jul 1995 | A |
5447533 | Vachon et al. | Sep 1995 | A |
5464427 | Curtis et al. | Nov 1995 | A |
5470334 | Ross et al. | Nov 1995 | A |
5531780 | Vachon | Jul 1996 | A |
5571139 | Jenkins, Jr. | Nov 1996 | A |
5573548 | Nazre et al. | Nov 1996 | A |
5593409 | Michelson | Jan 1997 | A |
5609635 | Michelson | Mar 1997 | A |
5609636 | Kohrs et al. | Mar 1997 | A |
5626613 | Schmieding | May 1997 | A |
5632747 | Scarborough | May 1997 | A |
5645547 | Coleman | Jul 1997 | A |
5658285 | Marnay et al. | Aug 1997 | A |
5676545 | Jones | Oct 1997 | A |
5681352 | Clancy, III et al. | Oct 1997 | A |
5688285 | Yamada | Nov 1997 | A |
5690676 | Dipoto et al. | Nov 1997 | A |
5695497 | Stahelin | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5709683 | Bagby | Jan 1998 | A |
5802794 | Robson | Sep 1998 | A |
5833715 | Vachon et al. | Nov 1998 | A |
5876405 | Del Rio | Mar 1999 | A |
5888227 | Cottle | Mar 1999 | A |
5891146 | Simon et al. | Apr 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5951560 | Simon et al. | Sep 1999 | A |
5961524 | Crombie | Oct 1999 | A |
5964783 | Grafton et al. | Oct 1999 | A |
5968047 | Reed | Oct 1999 | A |
5968098 | Winslow | Oct 1999 | A |
5984967 | Zdeblick et al. | Nov 1999 | A |
6008433 | Stone | Dec 1999 | A |
6039762 | McKay | Mar 2000 | A |
6086593 | Bonutti | Jul 2000 | A |
6096060 | Fitts et al. | Aug 2000 | A |
6097986 | Janke et al. | Aug 2000 | A |
6132435 | Young | Oct 2000 | A |
6146073 | Kobusch | Nov 2000 | A |
6196780 | Wakai et al. | Mar 2001 | B1 |
6214031 | Schmieding et al. | Apr 2001 | B1 |
6235057 | Roger et al. | May 2001 | B1 |
6283973 | Hubbard et al. | Sep 2001 | B1 |
6302632 | Lin | Oct 2001 | B1 |
6360129 | Ley et al. | Mar 2002 | B1 |
6443989 | Jackson | Sep 2002 | B1 |
6447545 | Bagby | Sep 2002 | B1 |
6488683 | Lieberman | Dec 2002 | B2 |
6503251 | Shadduck | Jan 2003 | B1 |
6511499 | Schmieding et al. | Jan 2003 | B2 |
6514257 | Dovesi et al. | Feb 2003 | B2 |
6517542 | Papay et al. | Feb 2003 | B1 |
6527774 | Lieberman | Mar 2003 | B2 |
6544265 | Lieberman | Apr 2003 | B2 |
6551319 | Lieberman | Apr 2003 | B2 |
6551320 | Lieberman | Apr 2003 | B2 |
6551322 | Lieberman | Apr 2003 | B1 |
6554830 | Chappius | Apr 2003 | B1 |
6569188 | Grafton et al. | May 2003 | B2 |
6589245 | Weiler et al. | Jul 2003 | B1 |
6604945 | Jones | Aug 2003 | B1 |
6626917 | Craig | Sep 2003 | B1 |
6648903 | Pierson | Nov 2003 | B1 |
6656183 | Colleran et al. | Dec 2003 | B2 |
6666888 | Jackson | Dec 2003 | B1 |
6685728 | Sinnott et al. | Feb 2004 | B2 |
6818010 | Eichhorn et al. | Nov 2004 | B2 |
6823871 | Schmieding | Nov 2004 | B2 |
6855168 | Crozet | Feb 2005 | B2 |
6857343 | Easterbrooks | Feb 2005 | B1 |
6863671 | Strobel | Mar 2005 | B1 |
6942669 | Kurc | Sep 2005 | B2 |
6953462 | Lieberman | Oct 2005 | B2 |
7033372 | Cahalan | Apr 2006 | B1 |
7070586 | Hart et al. | Jul 2006 | B2 |
7083647 | Sklar et al. | Aug 2006 | B1 |
7090690 | Foerster et al. | Aug 2006 | B2 |
7147641 | Chen | Dec 2006 | B2 |
7189251 | Kay | Mar 2007 | B2 |
7195634 | Schmieding et al. | Mar 2007 | B2 |
7217279 | Reese | May 2007 | B2 |
7322978 | West | Jan 2008 | B2 |
7322986 | Wolf | Jan 2008 | B2 |
7335221 | Collier et al. | Feb 2008 | B2 |
7371244 | Chatlynne et al. | May 2008 | B2 |
7572264 | Null et al. | Aug 2009 | B2 |
7575572 | Sweeney | Aug 2009 | B2 |
7585311 | Green et al. | Sep 2009 | B2 |
7594929 | Collette | Sep 2009 | B2 |
7608098 | Stone et al. | Oct 2009 | B1 |
7867252 | Criscuolo et al. | Jan 2011 | B2 |
7883529 | Sinnott et al. | Feb 2011 | B2 |
7896902 | Jeon et al. | Mar 2011 | B2 |
7914539 | Stone et al. | Mar 2011 | B2 |
7935138 | Richelsoph | May 2011 | B1 |
7993369 | Dreyfuss | Aug 2011 | B2 |
8016865 | Donnelly et al. | Sep 2011 | B2 |
8034090 | Stone et al. | Oct 2011 | B2 |
8167906 | Cauldwell et al. | May 2012 | B2 |
8343186 | Dreyfuss et al. | Jan 2013 | B2 |
8372124 | Paulk et al. | Feb 2013 | B2 |
8430909 | Dreyfuss | Apr 2013 | B2 |
8449613 | Crozet | May 2013 | B2 |
8480686 | Bakos | Jul 2013 | B2 |
8597328 | Cauldwell et al. | Dec 2013 | B2 |
8623049 | Ward | Jan 2014 | B2 |
8623052 | Dreyfuss et al. | Jan 2014 | B2 |
8636799 | Sklar et al. | Jan 2014 | B2 |
8672967 | Dimatteo et al. | Mar 2014 | B2 |
8715282 | Pool | May 2014 | B2 |
8801755 | Dreyfuss et al. | Aug 2014 | B2 |
8821541 | Dreyfuss et al. | Sep 2014 | B2 |
8974505 | Sawa et al. | Mar 2015 | B2 |
8979848 | Butters et al. | Mar 2015 | B2 |
8979865 | Fan et al. | Mar 2015 | B2 |
9155531 | Housman | Oct 2015 | B2 |
9162350 | Nino et al. | Oct 2015 | B2 |
9237887 | Wack et al. | Jan 2016 | B2 |
9308080 | Housman et al. | Apr 2016 | B2 |
9393006 | Housman et al. | Jul 2016 | B2 |
9427270 | Housman | Aug 2016 | B2 |
9526488 | Arai et al. | Dec 2016 | B2 |
9579188 | Bowman et al. | Feb 2017 | B2 |
20020022862 | Grafton et al. | Feb 2002 | A1 |
20020052629 | Morgan et al. | May 2002 | A1 |
20020055737 | Lieberman | May 2002 | A1 |
20020055738 | Lieberman | May 2002 | A1 |
20020055742 | Lieberman | May 2002 | A1 |
20020087189 | Bonutti | Jul 2002 | A1 |
20020087190 | Benavitz et al. | Jul 2002 | A1 |
20020099382 | Salazar et al. | Jul 2002 | A1 |
20020111653 | Foerster | Aug 2002 | A1 |
20020143335 | von Hoffmann et al. | Oct 2002 | A1 |
20020165546 | Goble et al. | Nov 2002 | A1 |
20030055431 | Brannon | Mar 2003 | A1 |
20030065361 | Dreyfuss | Apr 2003 | A1 |
20030065374 | Honeck | Apr 2003 | A1 |
20030069640 | Ferreira et al. | Apr 2003 | A1 |
20030078585 | Johnson et al. | Apr 2003 | A1 |
20030125749 | Yuan et al. | Jul 2003 | A1 |
20030181913 | Lieberman | Sep 2003 | A1 |
20030195529 | Takamoto et al. | Oct 2003 | A1 |
20040015170 | Tallarida et al. | Jan 2004 | A1 |
20040030343 | Kurc | Feb 2004 | A1 |
20040039404 | Dreyfuss | Feb 2004 | A1 |
20040073216 | Lieberman | Apr 2004 | A1 |
20040093032 | Sinnott et al. | May 2004 | A1 |
20040097945 | Wolf | May 2004 | A1 |
20040122424 | Ferree | Jun 2004 | A1 |
20040143158 | Hart et al. | Jul 2004 | A1 |
20040143237 | Hart et al. | Jul 2004 | A1 |
20040153074 | Bojarski et al. | Aug 2004 | A1 |
20040267265 | Kyle | Dec 2004 | A1 |
20050107828 | Reese | May 2005 | A1 |
20050159727 | Lesh | Jul 2005 | A1 |
20050222681 | Richley et al. | Oct 2005 | A1 |
20050234458 | Huebner | Oct 2005 | A1 |
20050250984 | Lam et al. | Nov 2005 | A1 |
20050250985 | Saadat et al. | Nov 2005 | A1 |
20050250987 | Ewers et al. | Nov 2005 | A1 |
20050250988 | Ewers et al. | Nov 2005 | A1 |
20050267478 | Corradi et al. | Dec 2005 | A1 |
20050283239 | Crozet | Dec 2005 | A1 |
20060009769 | Lieberman | Jan 2006 | A1 |
20060030948 | Manrique et al. | Feb 2006 | A1 |
20060079895 | McLeer | Apr 2006 | A1 |
20060079903 | Wong | Apr 2006 | A1 |
20060089651 | Trudeau et al. | Apr 2006 | A1 |
20060100627 | Stone et al. | May 2006 | A1 |
20060106390 | Jensen et al. | May 2006 | A1 |
20060142769 | Collette | Jun 2006 | A1 |
20060149266 | Cordasco | Jul 2006 | A1 |
20060217681 | Hart et al. | Sep 2006 | A1 |
20060241636 | Novak et al. | Oct 2006 | A1 |
20060247642 | Stone | Nov 2006 | A1 |
20060253080 | Tulleken et al. | Nov 2006 | A1 |
20060276841 | Barbieri et al. | Dec 2006 | A1 |
20070032797 | Ortiz et al. | Feb 2007 | A1 |
20070093895 | Donnelly et al. | Apr 2007 | A1 |
20070122764 | Balfour et al. | May 2007 | A1 |
20070142849 | Ewers et al. | Jun 2007 | A1 |
20070185532 | Stone et al. | Aug 2007 | A1 |
20070198019 | Schomer et al. | Aug 2007 | A1 |
20070203498 | Gerber et al. | Aug 2007 | A1 |
20080027446 | Stone et al. | Jan 2008 | A1 |
20080065114 | Stone et al. | Mar 2008 | A1 |
20080082128 | Stone | Apr 2008 | A1 |
20080132932 | Hoeppner | Jun 2008 | A1 |
20080140092 | Stone et al. | Jun 2008 | A1 |
20080140093 | Stone et al. | Jun 2008 | A1 |
20080154314 | McDevitt | Jun 2008 | A1 |
20080179839 | Walters | Jul 2008 | A1 |
20080275431 | Stone et al. | Nov 2008 | A1 |
20090024174 | Stark | Jan 2009 | A1 |
20090042951 | Danziger | Feb 2009 | A1 |
20090076544 | DiMatteo et al. | Mar 2009 | A1 |
20090118776 | Kelsch et al. | May 2009 | A1 |
20090125071 | Skinlo et al. | May 2009 | A1 |
20090187216 | Schmieding et al. | Jul 2009 | A1 |
20090248029 | Paulos | Oct 2009 | A1 |
20090292321 | Collette | Nov 2009 | A1 |
20090319043 | McDevitt et al. | Dec 2009 | A1 |
20100094297 | Parmigiani | Apr 2010 | A1 |
20100094352 | Iott et al. | Apr 2010 | A1 |
20100106166 | Cropper et al. | Apr 2010 | A1 |
20100274298 | Schiff | Oct 2010 | A1 |
20110054526 | Stone et al. | Mar 2011 | A1 |
20110112576 | Nguyen et al. | May 2011 | A1 |
20110130760 | Anderson et al. | Jun 2011 | A1 |
20110213426 | Yedlicka et al. | Sep 2011 | A1 |
20110224727 | Housman et al. | Sep 2011 | A1 |
20110282450 | Donnelly et al. | Nov 2011 | A1 |
20110319933 | Tepic | Dec 2011 | A1 |
20120041448 | Schumacher et al. | Feb 2012 | A1 |
20120059384 | Fan | Mar 2012 | A1 |
20120179163 | Housman et al. | Jul 2012 | A1 |
20120330420 | Brodke et al. | Dec 2012 | A1 |
20130150859 | Kehres et al. | Jun 2013 | A1 |
20130158596 | Miller et al. | Jun 2013 | A1 |
20130158597 | Hernandez | Jun 2013 | A1 |
20130158598 | Lizardi | Jun 2013 | A1 |
20130158599 | Hester et al. | Jun 2013 | A1 |
20130158610 | Hernandez | Jun 2013 | A1 |
20130178901 | Arai et al. | Jul 2013 | A1 |
20140081339 | Bowman et al. | Mar 2014 | A1 |
20140142697 | Sklar et al. | May 2014 | A1 |
20140148850 | Dimatteo et al. | May 2014 | A1 |
20140172016 | Housman | Jun 2014 | A1 |
20140277129 | Arai et al. | Sep 2014 | A1 |
20140277130 | Housman | Sep 2014 | A1 |
20140277188 | Poulos | Sep 2014 | A1 |
20140277192 | Housman | Sep 2014 | A1 |
20150196388 | Housman et al. | Jul 2015 | A1 |
20150327984 | Arai et al. | Nov 2015 | A1 |
20160235399 | Housman et al. | Aug 2016 | A1 |
20160374661 | Housman et al. | Dec 2016 | A1 |
20170014224 | Arai et al. | Jan 2017 | A1 |
20170020589 | Bowman et al. | Jan 2017 | A1 |
20170049438 | Arai et al. | Feb 2017 | A1 |
Number | Date | Country |
---|---|---|
2732211 | Oct 2005 | CN |
1701772 | Nov 2005 | CN |
1829479 | Sep 2006 | CN |
101002703 | Jul 2007 | CN |
101031248 | Sep 2007 | CN |
101422381 | May 2009 | CN |
101422381 | May 2009 | CN |
101573078 | Nov 2009 | CN |
201436022 | Apr 2010 | CN |
102068305 | May 2011 | CN |
102475586 | May 2012 | CN |
102512253 | Jun 2012 | CN |
102525583 | Jul 2012 | CN |
102551821 | Jul 2012 | CN |
102781370 | Nov 2012 | CN |
102905636 | Jan 2013 | CN |
102573662 | Aug 2015 | CN |
3502698 | Sep 1992 | EP |
05202698 | Sep 1992 | EP |
0538895 | Apr 1993 | EP |
0682917 | Nov 1995 | EP |
0686373 | Dec 1995 | EP |
0669110 | May 2000 | EP |
1147751 | Oct 2001 | EP |
1093774 | Jun 2002 | EP |
1234637 | Aug 2002 | EP |
0796593 | May 2004 | EP |
1430843 | Jun 2004 | EP |
1917926 | Jul 2008 | EP |
2036501 | Sep 2010 | EP |
2422711 | Feb 2012 | EP |
2422712 | Feb 2012 | EP |
2596758 | May 2013 | EP |
2601894 | Jun 2013 | EP |
2760355 | Sep 1998 | FR |
2803739 | Jul 2001 | FR |
2846867 | May 2004 | FR |
2879915 | Jun 2006 | FR |
2879915 | Jun 2006 | FR |
2294399 | May 1996 | GB |
H10-000200 | Jan 1998 | JP |
H10200 | Jan 1998 | JP |
2005-529650 | Oct 2005 | JP |
2006-212449 | Aug 2006 | JP |
2006-305348 | Nov 2006 | JP |
9608205 | Mar 1996 | WO |
1996-19947 | Jul 1996 | WO |
9619947 | Jul 1996 | WO |
1998-02117 | Jan 1998 | WO |
9802117 | Jan 1998 | WO |
9826717 | Jun 1998 | WO |
2003-063713 | Aug 2003 | WO |
03063713 | Aug 2003 | WO |
03103507 | Dec 2003 | WO |
03103507 | Dec 2003 | WO |
2006055516 | May 2006 | WO |
2007093192 | Aug 2007 | WO |
2008-021474 | Feb 2008 | WO |
2008021474 | Feb 2008 | WO |
2008100944 | Aug 2008 | WO |
2009-042951 | Apr 2009 | WO |
2009042951 | Apr 2009 | WO |
2010009217 | Jan 2010 | WO |
2010017631 | Feb 2010 | WO |
20100017584 | Feb 2010 | WO |
2010053708 | May 2010 | WO |
2011059995 | May 2011 | WO |
2011060022 | May 2011 | WO |
2011112776 | Sep 2011 | WO |
20110112576 | Sep 2011 | WO |
20120129388 | Sep 2012 | WO |
2012171011 | Dec 2012 | WO |
Entry |
---|
First Office Action for Chinese Patent Application No. 201180013194.3, dated Jul. 21, 2014. |
International Search and Written Opinion for PCT/US2014/022539 dated Jun. 27, 2014. |
International Search and Written Opinion for PCT/US2014/020747 dated Jun. 6, 2014. |
Decision of Rejections for Japanese Patent Application No. 2011-538642, dated Jun. 2, 2014. |
International Search and Written Opinion for PCT/US2014/066389 dated Feb. 17, 2015. |
Notice of Reasons for Rejection for Japanese Patent Application No. 2012-557236 dated Mar. 2, 2015. |
Patent Examination Report No. 1 for Australian Patent Application No. 2011224326 dated Apr. 21, 2015. |
Second Office Action for Chinese Patent Application No. 201180013194.3, dated Mar. 23, 2015. |
First Office Action for Chinese Patent Application No. 201280022627.6, dated Apr. 13, 2015. |
Second Office Action for related Chinese Patent Application No. 201280022627.6 dated Sep. 16, 2015. |
Substantive Examination for related Mexican Patent Application No. Mx/a/2013/010383 issued Aug. 12, 2015. |
Patent Examination Report No. 1 for related Australian Patent Application No. 2012229152 Issued Aug. 18, 2015. |
Third Office Action for related Chinese Patent Application No. 2011-80013194.3 issued Aug. 21, 2015. |
International Preliminary Report on Patentability for related International Application No. PCT/US2014/033535, dated Oct. 22, 2015. |
Decision of Rejection on related Japanese Patent Application No. 2012-557236 dated Oct. 9, 2015. |
Communication from related European Patent Application No. 09761114.9 dated Dec. 3, 2015. |
Communication from related European Patent Application No. 11710940.5 dated Dec. 8, 2015. |
First Office Action for related Chinese Patent Application No. 201280038677.3 dated Sep. 6, 2015. |
Patent Examination Report No. 1 for related Australian Patent Application No. 2012267924 dated Dec. 22, 2015. |
Substantive Examination Report from related Mexico Patent Application No. MX/a/2013/010383 dated Jan. 19, 2016. |
Notice of Reasons for Rejection for related Japanese Application No. 2013-558094 dated Feb. 2, 2016. |
Substantive Examination of related Russian Application No. 2013144961/14(069526) dated Dec. 23, 2015. |
Third Office Action from related Chines Application No. 201280022627.6 dated Mar. 4, 2016. |
Second Office Action from related Chinese Application No. 201280038677.3 dated May 5, 2016. |
International Preliminary Report on Patentability from related PCT Application No. PCT/US2014/066389 dated May 24, 2016. |
Office Action from related Mexican Application No. MX/a/2013/010383 dated May 3, 2016. |
Notice of Reasons for Rejection from related Japanese Application No. 2014-514625 dated Jun. 13, 2016. |
Communication from EPO from related European Application No. 12711719.0-1666 dated Jul. 28, 2016. |
Office Action from related Russian Application No. 2015147534/20(073143) dated Jun. 29, 2016. |
Hunt, Patrick, D.V.M. et al. “Development of a Perforated Biodegradable Interference Screw” , Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 21, No. 3, Mar. 2005; pp. 258-265. |
International Search and Written Opinion for PCT/US2011/027837 dated May 19, 2011. |
Smith & Nephew brochure titled “Bio RCITM Bioabsorbable Screws: Anatomically Targeted Screws for ACL and PCL Reconstruction”, 2000. |
Biomet brochure “Bio-CoreTM Interference Screw”, 2007. |
International Search and Written Opinion for PCT/US2009/065304 dated Jun. 5, 2013. |
International Search and Written Opinion for PCT/US2012/041298 dated Jun. 5, 2013. |
International Search and Written Opinion for PCT/US2012/028803 dated Oct. 24, 2010. |
Notice of Reasons for Rejections for Japanese Patent Application No. 2011-538642, dated Oct. 1, 2013. |
First Office Action for Chinese Patent Application No. 200980155954.7, dated Apr. 12, 2013. |
Second Office Action for Chinese Patent Application No. 200980155954.7, dated Oct. 24, 2013. |
Notice of Reasons for Rejection for Japanese Patent Application No. 2012-557236 dated Nov. 25, 2014. |
Patent Examination Report No. 1 for Australian Patent Application No. 2009319879 dated Nov. 10, 2014. |
Office Action and Search Report from related Chinese Application No. 201480032876.2 dated Oct. 19, 2016. |
Office Communication from related European Application No. 14712930.8-1662 dated Nov. 24, 2016. |
Decision of Rejection from related Japanese Application No. 2013-558094 dated Sep. 5, 2016. |
First Office Action from related Chinese Application No. 201480012203.0 dated Aug. 17, 2016. |
Third Office Action from related Chinese Application No. 201280038677.3 dated Nov. 28, 2016. |
Office Action from related Japanese Application No. 2014-514625 dated Dec. 19, 2016. |
Office Action from related Russian Application No. 2016124173/20(037886) dated Jan. 19, 2017. |
Office Action from related EPO Application No. 14716107.9-1664 dated Mar. 23, 2017. |
Communication from related European Application No. 14724272.1-1664 issued Jun. 13, 2017. |
First Office Action for Chinese Patent Application No. 201480073698.8 issued May 2, 2017. |
First Office Action from related Chinese Application No. 201480014353.5 issued Apr. 19, 2017. |
Fourth Office Action from related Chinese Application No. 201280038677.3 issued May 26, 2017. |
International Search and Written Opinion for PCT/US2014/033535 dated Jul. 18, 2014. |
Office Action from related Russian Application No. 2015147534/20(073143) issued Jun. 29, 2016. |
Second Office Action for Chinese Patent Application No.: 201180013194.3, issued Mar. 23, 2015. |
Second Office Action from related Chinese Application No. 201480012203.0 issued Apr. 24, 2017. |
Second Office Action from related Chinese Application No. 201480032876.2 issued May 31, 2017. |
Number | Date | Country | |
---|---|---|---|
20140303676 A1 | Oct 2014 | US |
Number | Date | Country | |
---|---|---|---|
61810007 | Apr 2013 | US |